Insider Trading: BioScrip Inc (BIOS.OQ)
BIOS.OQ on NASDAQ Stock Exchange Global Select Market
13.21USD
20 May 2013
13.21USD
20 May 2013
Price Change (% chg)
$-0.08 (-0.60%)
$-0.08 (-0.60%)
Prev Close
$13.29
$13.29
Open
$13.31
$13.31
Day's High
$13.31
$13.31
Day's Low
$13.09
$13.09
Volume
122,787
122,787
Avg. Vol
191,415
191,415
52-wk High
$14.73
$14.73
52-wk Low
$6.15
$6.15
FRIEDMAN RICHARD H
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 17 Apr 2012 | Buy | 2,000 | $6.36 | 382,179 |
| 17 Apr 2012 | Sell | 2,400 | $7.04 | 382,179 |
| 17 Apr 2012 | Sell | 2,000 | $7.03 | 382,179 |
| 16 Apr 2012 | Buy | 14,900 | $6.36 | 382,179 |
| 16 Apr 2012 | Sell | 15,000 | $7.01 | 382,179 |
| 16 Apr 2012 | Sell | 14,900 | $7.01 | 382,179 |
| 11 Apr 2012 | Sell | 4,700 | $7.00 | 399,579 |
| 11 Apr 2012 | Buy | 250,000 | $0.00 | 399,579 |
| 11 Apr 2012 | Sell | 4,000 | $7.00 | 399,579 |
| 11 Apr 2012 | Buy | 4,000 | $6.36 | 399,579 |
| 11 Apr 2012 | Sell | 250,000 | $0.00 | 399,579 |
| 2 Apr 2012 | Buy | 55,386 | $5.80 | 404,279 |
| 2 Apr 2012 | Buy | 59,214 | $6.36 | 404,279 |
| 2 Apr 2012 | Sell | 114,600 | $7.02 | 404,279 |
| 1 Apr 2012 | Sell | 36,312 | $7.00 | 404,279 |
| 1 Apr 2012 | Buy | 36,312 | $5.80 | 404,279 |
| 18 Mar 2012 | Sell | 100,000 | $6.77 | 404,279 |
| 8 Mar 2012 | Buy | 66,667 | $3.46 | 580,946 |
| 8 Mar 2012 | Buy | 10,000 | $2.73 | 580,946 |
| 8 Mar 2012 | Sell | 28,500 | $7.01 | 580,946 |
| 8 Mar 2012 | Sell | 76,667 | $7.04 | 580,946 |
| 29 Feb 2012 | Buy | 20,000 | $2.73 | 532,779 |
| 29 Feb 2012 | Sell | 20,000 | $6.40 | 532,779 |
| 1 Feb 2012 | Sell | 40,000 | $6.34 | 532,779 |
| 1 Feb 2012 | Buy | 40,000 | $2.73 | 532,779 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 165 |
| Total Shares Held: | 70,475,343 |
| 3 Mo. Net Change: | 356,367 |
| # New Positions: | 28 |
| # Closed Positions: | 9 |
| # Increased Positions: | 76 |
| # Reduced Positions: | 63 |
| # Net Buyers: | 13 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Myron Holubiak |
66 | 2012 | Independent Chairman of the Board |
Richard Smith |
53 | 2011 | President, Chief Executive Officer, Chief Operating Officer, Director |
Hai Tran |
43 | 2012 | Chief Financial Officer, Treasurer |
Brian Stiver |
50 | 2012 | Senior Vice President - National Infusion Sales |
Vito Ponzio |
58 | 2010 | Senior Vice President - Human Resources |
David Evans |
48 | 2009 | Senior Vice President - Strategic Operations |
Barbara Cormier |
69 | 2012 | Chief Compliance Officer and Privacy Officer |
Patricia Bogusz |
53 | 2011 | Vice President - Finance, Principal Accounting Officer |
Daniel Colucci |
47 | 2011 | Vice President - PBM Services |
Charlotte Collins |
60 | 2003 | Independent Director |
Samuel Frieder |
48 | 2010 | Independent Director |
David Hubers |
70 | 2005 | Independent Director |
Richard Robbins |
72 | 2005 | Independent Director |
Stuart Samuels |
71 | 2005 | Independent Director |
Gordon Woodward |
44 | 2010 | Independent Director |
Lisa Carlton-Wilson |
President |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
